This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
To learn more about the International OCD Foundation’s 23rd Annual OCD Conference, please visit http://ocd2016.org.
View analytic
Friday, July 29 • 9:15am - 10:45am
50 Years of Medically-Based Treatment in OCD: Past, Present and Future

Sign up or log in to save this to your schedule and see who's attending!

It has been nearly 50 years since Lopez-Ibor published the clinical observation that clomipramine appeared effective in OCD. In 1976, Yaryura-Tobias hypothesized that clomipramine’s effects on serotonin were central to its efficacy in OCD. In 1986, the IOCDF was formed in the context of large-scale clinical trials of clomipramine and other randomized controlled studies of what was then a new generation of SSRIs, such as fluvoxamine. Given that this year marks the 30th Anniversary of the IOCDF, this talk will reflect on what we have learned about medication treatment for OCD and chart a path to the future. The number of available research-proven options are few, and thus the panel of experts will focus mostly on strategies for future drug and device development.


Wayne Goodman, MD

Dr. Goodman has conducted research on the phenomenology, neurobiology and treatment of OCD and is the principal developer of the Y-BOCS. He is co-founder of the IOCDF. Dr. Goodman is also recognized for his work on Deep Brain Stimulation for intractable psychiatric disorders. A graduate of Columbia University with a BS in electrical engineering, Dr. Goodman received his medical degree from Boston University and completed his internship... Read More →

Benjamin Greenberg, MD, PhD

Dr. Greenberg's background includes psychology (BA, Amherst College), neuroscience (PhD, UC San Diego), and medicine (MD, University of Miami), He was a neurology resident at Columbia University, and completed psychiatry residency at Johns Hopkins Hospital. He was a fellow and later Chief of adult OCD research at the NIMH (intramural program). His primary research since 2000 has been psychiatric neurosurgery, for which he is internationally... Read More →

Christopher Pittenger, MD, PhD

Christopher Pittenger is Associate Professor of Psychiatry at Yale and Director of the Yale OCD Research Clinic. He received his MD-Ph.D. from Columbia University, where his Ph.D. studies, performed with Nobel Prize winner Eric Kandel, focused on elucidating the mechanisms of brain processes that underlie behavioral change. His current research studies, both in the lab and in the clinic, focus on elucidating the brain abnormalities... Read More →

H. Blair Simpson, MD, PhD

Helen Blair Simpson, M.D., Ph.D., is Professor of Psychiatry at Columbia University Medical College, and Director of the Anxiety Disorders Clinic and the Center for Obsessive-Compulsive and Related Disorders. Funded by the National Institutes of Mental Health, she uses clinical trials to study current treatments for anxiety and OCD and collaborates with basic scientists and neuroimagers to study underlying brain mechanisms. She helped develop... Read More →

Friday July 29, 2016 9:15am - 10:45am
Salon III, 7th Floor